Clinical Trial

Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)

Study acronym: COR-SHOCK
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate the clinical outcomes and management approaches of cardiogenic shock throughout the years in adult patients admitted to a Cardiology Department. The main questions it aims to answer are: * How have management strategies and clinical outcomes for cardiogenic shock evolved over time? * How do clinical, laboratory, and advanced hemodynamic monitoring parameters relate to patient survival and overall prognosis in this population? Researchers will evaluate clinical data collected from 2017 onwards to see if therapeutic advancements and changes in clinical management over the years have led to improved patient survival and quality of care. Participants will: * Receive standard, routine medical care for cardiogenic shock as determined by their clinical team (no experimental interventions will be introduced). * Have their clinical, laboratory, and imaging data collected from hospital electronic records during their stay. * Be followed for up to 1 year after hospital admission to evaluate long-term survival and clinical outcomes.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-12
notable Primary completion pushed: 2030-12-31 -> 2036-12-31 2026-06-12
minor Completion pushed: 2030-12-31 -> 2036-12-31 2026-06-12
Trial Details
NCT Number NCT07597291
Lead Sponsor Hospital de Santa Cruz, Portugal
Conditions Cardiogenic Shock Acute, Cardiogenic Shock, Cardiogenic Shock Post Myocardial Infarction
Enrollment 800 participants
Start Date 2026-06-10
Primary Completion 2036-12-31 (estimated)
Study Completion 2036-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-11